Cases
ARMO BioSciences, Inc. (NASDAQ: ARMO)
Merger
Overview
Overview
- Date:
- 5/10/2018
- Company Name:
- ARMO BioSciences, Inc.
- Stock Symbol:
- ARMO
- Company Name - Buyer:
- Eli Lilly and Company
- Stock Symbol - Buyer:
- LLY
- Status:
- Closed/Complete
NEW YORK, May 10, 2018 – Bragar Eagel & Squire, P.C. is investigating potential claims on behalf of ARMO BioSciences, Inc. (NASDAQ: ARMO) stockholders concerning the proposed acquisition of the company by Eli Lilly and Company (NYSE: LLY).
Our investigation concerns whether ARMO’s board of directors failed to adequately shop the Company and obtain the best possible value for its stockholders before entering into a definitive merger agreement with Eli Lilly. Under the terms of the agreement, ARMO stockholders will receive $50.00 per share in cash for each ARMO share that they own.
If you own ARMO shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.
Our investigation concerns whether ARMO’s board of directors failed to adequately shop the Company and obtain the best possible value for its stockholders before entering into a definitive merger agreement with Eli Lilly. Under the terms of the agreement, ARMO stockholders will receive $50.00 per share in cash for each ARMO share that they own.
If you own ARMO shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.